Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;

> Pennsylvania has offered Endo Pharmaceuticals ($ENDP) $1.2 million in incentives to remain in The Keystone State in exchange for a promise of 154 jobs in three years. Story

> Wellspring Pharmaceutical, a Canadian manufacturer of specialty and OTC drugs, has been acquired by Sentinel Capital Partners and Ancor Capital Partners. Release

> Hebei Aoxing Pharmaceutical Group, unit of China's Aoxing Pharmaceuticals ($AXN), has received government funding of $315,000 for manufacturing plant improvements. News

> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate. Release

> Kenya's Universal Corp. has been prequalified by the World Health Organization to manufacture the HIV drug, Lamozido. Item

> A news organization's investigation has uncovered drug counterfeiting operations in parts of Delhi and adjoining western parts of Uttar Pradesh. Story

> Organization and funding troubles plague U.S. efforts to develop and produce bioterror vaccines. Story

> Adeona Pharmaceuticals ($AEN) will provide commercial-scale manufacturing for Chicago-based F&F Foods of wellZin, an oral zinc lozenge to ease symptoms of the common cold. Release

> The FDA will provide $2 million in support of two regulatory science and innovation centers at the University of Maryland and Georgetown University. Story